Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

PGEN

Live52w high -25.5%

Annual Quarterly

Core line items from PGEN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

Log in Get Started

Annual Quarterly

Entity: PRECIGEN, INC.·Source: SEC EDGAR companyfacts·Next-Q consensus from Finnhub

Metric	Q3 2026 (Est.) Expected 2026-08-10	Q1 2026 2026-03-31	Annual 2025 2025-12-31	Q1 2025 2025-03-31	Annual 2024 2024-12-31
Revenue	$29.17M	$23.25M	$9.68M	$1.34M	$3.92M
Operating Income	Not available	$-5.99M	$-110.51M	$-22.60M	$-135.03M
Net Income	Not available	$-7.93M	$-250.64M	$-54.15M	$-126.23M
EPS (Diluted)	$-0.02	$-0.02	$-1.37	$-0.18	$-0.47
Total Assets	Not available	$138.63M	$155.50M	$128.79M	$145.27M
Total Liabilities	Not available	$118.39M	$134.59M	$113.33M	$78.53M
Cash & Equivalents	Not available	$7.48M	$30.23M	$6.06M	$29.52M
Free Cash Flow OCF − CapEx	Not available	$-44.09M	$-89.83M	$-16.95M	$-76.76M
Shares Outstanding	Not available	355.90M	353.91M	295.14M	292.87M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data. The amber (Est.) column shows Wall Street analyst consensus for the next reporting period — only Revenue and EPS are covered by published consensus, so other line items remain blank. These are third-party estimates, not company guidance.

Core line items from PGEN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

52w high -25.5%

Entity: PRECIGEN, INC.·Source: SEC EDGAR companyfacts·Next-Q consensus from Finnhub

Metric	Q3 2026 (Est.) Expected 2026-08-10	Q1 2026 2026-03-31	Annual 2025 2025-12-31	Q1 2025 2025-03-31	Annual 2024 2024-12-31
Revenue	$29.17M	$23.25M	$9.68M	$1.34M	$3.92M
Operating Income	Not available	$-5.99M	$-110.51M	$-22.60M	$-135.03M
Net Income	Not available	$-7.93M	$-250.64M	$-54.15M	$-126.23M
EPS (Diluted)	$-0.02	$-0.02	$-1.37	$-0.18	$-0.47
Total Assets	Not available	$138.63M	$155.50M	$128.79M	$145.27M
Total Liabilities	Not available	$118.39M	$134.59M	$113.33M	$78.53M
Cash & Equivalents	Not available	$7.48M	$30.23M	$6.06M	$29.52M
Free Cash Flow OCF − CapEx	Not available	$-44.09M	$-89.83M	$-16.95M	$-76.76M
Shares Outstanding	Not available	355.90M	353.91M	295.14M	292.87M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data. The amber (Est.) column shows Wall Street analyst consensus for the next reporting period — only Revenue and EPS are covered by published consensus, so other line items remain blank. These are third-party estimates, not company guidance.